Concepedia

Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors

C.J.A. van Moorsel, Judith R. Kroep, Herbert M. Pinedo, G. Veerman, Daphne Voorn, Pieter E. Postmus, Jan B. Vermorken, C.J. van Groeningen, W. J. F. van der Vijgh, Godefridus J. Peters

Annals of Oncology · 1999 · 88 citations · 32 references

DOIFull text

Open access

Concepts

References

32

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

Anne Marie J. Fichtinger-Schepman, J. L. VAN DER VEER, Jeroen H. J. Den Hartog et al. · Biochemistry · 1985 · 1K citations

, , +8

Action of 2',2'-difluorodeoxycytidine on DNA synthesis.

Peng Huang, Sherri Chubb, Larry W. Hertel et al. · PubMed · 1991 · 884 citations

, , +11

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

James L. Abbruzzese, Ralf Grunewald, Elizabeth A. Weeks et al. · Journal of Clinical Oncology · 1991 · 759 citations

, , +13

A phase II study

Philippe Rougier, Antoine Adenis, Michel Ducreux et al. · European Journal of Cancer · 2000 · 752 citations

, , +4

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.

Volker Heinemann, Larry W. Hertel, Gerald B. Grindey et al. · PubMed · 1988 · 509 citations

, , +13